COLLINO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 12.883
EU - Europa 7.638
AS - Asia 5.019
SA - Sud America 179
OC - Oceania 86
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 35
Totale 25.905
Nazione #
US - Stati Uniti d'America 12.694
CN - Cina 2.734
IT - Italia 1.942
IE - Irlanda 1.023
SE - Svezia 803
SG - Singapore 714
DE - Germania 688
FR - Francia 515
GB - Regno Unito 481
UA - Ucraina 452
FI - Finlandia 442
DK - Danimarca 382
VN - Vietnam 339
KR - Corea 300
PL - Polonia 274
JP - Giappone 236
ID - Indonesia 164
IN - India 122
CA - Canada 119
HK - Hong Kong 116
AT - Austria 105
BR - Brasile 94
ES - Italia 92
TW - Taiwan 82
AU - Australia 78
BE - Belgio 70
NL - Olanda 70
TR - Turchia 67
RU - Federazione Russa 64
MX - Messico 58
RO - Romania 49
CH - Svizzera 34
EU - Europa 33
GR - Grecia 31
EG - Egitto 30
AR - Argentina 25
NO - Norvegia 25
CZ - Repubblica Ceca 23
IL - Israele 22
IR - Iran 21
CL - Cile 20
HU - Ungheria 17
TH - Thailandia 17
CO - Colombia 15
MY - Malesia 15
PH - Filippine 14
SN - Senegal 13
PT - Portogallo 12
UZ - Uzbekistan 11
SA - Arabia Saudita 10
PE - Perù 9
NZ - Nuova Zelanda 8
BG - Bulgaria 7
DZ - Algeria 7
BD - Bangladesh 6
EC - Ecuador 6
MO - Macao, regione amministrativa speciale della Cina 6
SI - Slovenia 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
KZ - Kazakistan 4
PK - Pakistan 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BZ - Belize 3
CU - Cuba 3
HN - Honduras 3
MK - Macedonia 3
UY - Uruguay 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
CI - Costa d'Avorio 2
EE - Estonia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
PR - Porto Rico 2
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
IM - Isola di Man 1
KH - Cambogia 1
KM - Comore 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PY - Paraguay 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 25.904
Città #
Ann Arbor 1.470
Chandler 1.390
Dublin 1.016
Beijing 981
Fairfield 885
Houston 617
Ashburn 594
Singapore 561
Torino 505
Wilmington 486
Woodbridge 416
Seattle 371
Dearborn 334
Pisa 332
Jacksonville 324
Villeurbanne 318
Cambridge 309
Nyköping 275
Medford 264
Princeton 261
Redwood City 251
Warsaw 250
Dong Ket 237
Columbus 229
Santa Clara 180
Shanghai 175
Turin 159
Jakarta 158
Nanjing 142
Guangzhou 137
London 115
Frankfurt am Main 107
Vienna 89
Fremont 84
Milan 81
Boston 79
San Diego 74
Boardman 71
Wuhan 62
Hangzhou 57
Xian 53
Chengdu 50
Taipei 49
Hefei 48
Helsinki 48
Rome 46
Tokyo 45
Brussels 44
Chongqing 44
Zhengzhou 43
Changsha 42
Lappeenranta 42
New York 42
Norwalk 40
Phoenix 40
Washington 36
Toronto 35
Hong Kong 34
Munich 34
Hebei 32
Seoul 32
Shenyang 32
Jena 30
Ottawa 27
Silver Spring 26
Jinan 25
Central District 23
Shenzhen 23
Central 22
Falls Church 22
Los Angeles 22
Aachen 21
Paris 21
Verona 21
Fort Worth 20
Osaka 20
Pune 19
Berlin 18
Harbin 18
Kunming 18
Upper Marlboro 18
Tianjin 17
Bari 16
Nuremberg 16
Oslo 16
San Francisco 16
Eschweiler 15
Hamburg 15
Santiago 15
São Paulo 15
Ankara 14
Changchun 14
Düsseldorf 14
Madrid 14
Pittsburgh 14
Amsterdam 13
Barcelona 13
Mountain View 13
Nanchang 13
Des Moines 12
Totale 16.046
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.255
Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation 551
Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock 502
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 444
Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options 416
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 324
Advanced glycation end products as biomarkers in systemic diseases: Premises and perspectives of salivary advanced glycation end products 320
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 316
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 312
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 312
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 296
PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss 295
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 284
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 274
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 272
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 266
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 247
DUAL SECOND DIMENSION COLUMN-DUAL DETECTION IN TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY (GC×2GC-MS/FID): INCREASED INFORMATION IN OPTIMIZED SEPARATION CONDITIONS IN METABOLOMICS 235
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock 235
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 227
Acute treatment with bone marrow-derived mononuclear cells attenuates the organ injury/dysfunction induced by hemorrhagic shock in the rat. 224
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 223
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 221
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 218
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD 217
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. 214
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 212
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 204
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry 198
Urinary metabolic fingerprinting of mice with diet-induced metabolic derangements by parallel dual secondary column-dual detection two-dimensional comprehensive gas chromatography 195
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 194
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 193
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 185
Neuronal nitric oxide synthase is involved in vascular hyporeactivity and multiple organ dysfunction associated with hemorrhagic shock 184
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 183
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 183
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 182
Overexpression of histamine H4 receptors in the kidney of diabetic rat 181
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes 179
The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications. 178
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 177
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor. 175
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 174
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 172
Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. 171
Effects of a semi-synthetic N-,O-sulfated glycosaminoglycan K5 polysaccharide derivative in a rat model of cerebral ischaemia/reperfusion injury 166
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury. 166
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 155
Cannabis FM2: optimization and standardization of galenic preparations. 153
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 152
Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation 150
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 147
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes 144
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 144
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 143
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders. 142
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2” 142
Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications 141
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis 134
The Anti-Malarial Drug Artesunate Attenuates Cardiac Injury in a Rodent Model of Myocardial Infarction 131
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 129
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 129
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 124
Effects of High Intakes of Fructose and Galactose, with or without Added Fructooligosaccharides, on Metabolic Factors, Inflammation, and Gut Integrity in a Rat Model 124
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis 124
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 123
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 123
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice 123
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 122
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 122
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB 121
Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury. 120
Angiotensin II induces tumor necrosis factor-alpha expressionand release from cultured human podocytes 119
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway 118
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 114
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow. 112
Erythropoietin in the intensive care unit: beyond treatment of anemia. 111
A non-erythropoietic peptide that mimicks the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. 103
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study 103
Modulazione farmacologica della patologia ischemica: studio degli effetti dei ligandi di PPAR 101
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 100
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 100
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 99
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 99
Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure. 98
Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation 98
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 98
The cardiac dysfunction caused by sepsis in animals with chronic kidney disease is attenuated by inhibiting I kappa B kinase 97
Transient expression of reck under hepatic ischemia/reperfusion conditions is associated with mapk signaling pathways 97
Immunotossicologia 96
‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats 96
Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor. 94
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 94
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 94
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 94
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 94
Activation of Ppar-beta/delta attenuates mycardial ischemia/reperfusion injury in the rat 93
Acute treatment with relaxin attenuates the injury/ dysfunction induced by renal ischemia/reperfusion injury. 93
Mediators of Interorgan Crosstalk in Metabolic Inflammation 93
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 93
Totale 18.715
Categoria #
all - tutte 70.854
article - articoli 0
book - libri 0
conference - conferenze 22.161
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.893 0 0 0 0 345 509 427 343 416 344 275 234
2020/20213.734 253 225 203 279 369 285 268 256 360 335 232 669
2021/20224.080 293 288 278 352 270 227 261 312 202 305 687 605
2022/20234.582 491 347 136 436 390 1.077 328 292 637 120 183 145
2023/20242.202 250 285 121 112 179 245 117 137 41 179 247 289
2024/20251.780 92 285 309 531 563 0 0 0 0 0 0 0
Totale 26.945